Mira Pharmaceuticals Inc (MIRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,824 | 3,529 | 4,603 | 5,868 | 25 |
| Receivables | N/A | N/A | 12 | N/A | N/A |
| Other current assets | 0 | 0 | 0 | 0 | 353 |
| TOTAL | $2,932 | $3,714 | $4,858 | $6,071 | $421 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 83 | 95 | 74 | 2,947 | 3,404 |
| TOTAL | $83 | $95 | $74 | $2,947 | $3,404 |
| Total Assets | $3,016 | $3,809 | $4,932 | $9,018 | $3,825 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 1,803 |
| Accounts payable and accrued liabilities | 782 | 636 | 539 | 780 | 659 |
| Accrued Expenses | 15 | 15 | 15 | 15 | 40 |
| TOTAL | $797 | $652 | $558 | $868 | $2,577 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 35 | 52 |
| TOTAL | $N/A | $N/A | $N/A | $35 | $52 |
| Total Liabilities | $797 | $652 | $558 | $903 | $2,629 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,781 | 14,781 | 14,781 | 14,781 | 14,781 |
| Common Shares | 2 | 2 | 2 | 2 | 7 |
| Retained earnings | -24,694 | -23,003 | -21,285 | -15,498 | -11,910 |
| TOTAL | $2,219 | $3,157 | $4,374 | $8,115 | $1,197 |
| Total Liabilities And Equity | $3,016 | $3,809 | $4,932 | $9,018 | $3,825 |